Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis

OBJECTIVE: This observational cohort study investigated the impact of biological (b) disease-modifying antirheumatic drugs (DMARDs) on the outcomes of serious infections (SIs) in patients with rheumatoid arthritis. METHODS: We investigated outcomes of SIs observed in 947 patients enrolled in the Ger...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Rheum Dis
Autores principales: Richter, A, Listing, J, Schneider, M, Klopsch, T, Kapelle, A, Kaufmann, J, Zink, A, Strangfeld, A
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013078/
https://ncbi.nlm.nih.gov/pubmed/26567181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-207838
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares